COMMUNIQUÉS West-GlobeNewswire

NurExone Advances Optic Nerve Injury Program Toward Larger-Animal Study, Following Positive Preclinical Results
09/10/2026
Preclinical Results at Sheba Medical Center Demonstrate Retinal Recovery with NurExone’s Exosome-based Lead Candidate TORONTO and HAIFA, Israel, Oct. 09, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) ( [...]
Mangoceuticals Closes Registered Direct Offering Priced at 74% Premium to Recent Market Close
09/10/2026
Transaction follows a $2.5 million strategic investment commitment at MangoRx IP Holdings to support intellectual property commercialization DALLAS, TX, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: [...]
MESA LABS DECLARES QUARTERLY DIVIDEND
09/10/2026
Lakewood, Colo., Oct. 09, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0 [...]
RadiusXR and Topcon Healthcare Inc. Introduce InspirePRO: The New Standard in Visual Field Testing
09/10/2026
RadiusXR and Topcon Healthcare, Inc. unveil InspirePRO at AAO: the full measurement range expertly engineered into a lightweight wearable experience. Purpose-built medical-grade perimeter combines comprehensive glaucoma [...]
Metro ENT Joins National Breathe Free Network, Beginning Its Next Chapter of ENT Care in the Dallas Area
09/10/2026
Partnership builds on Metro ENT’s established physician leadership while adding the resources and infrastructure of the National Breathe Free network. MESQUITE, Texas, Oct. 09, 2026 (GLOBE NEWSWIRE) -- National Breathe [...]
AB Science today reports its revenues for the first half of 2026 and provides an update on its activities
09/10/2026
PRESS RELEASE AB SCIENCE REPORTS ITS FINANCIAL RESULTS FOR THE FIRST HALF OF 2026 AND KEY EVENTS OF THE PERIOD Change in AB Science's governance and implementation of a new strategy Appointment of Stéphane Ledermann as [...]
AB Science annonce aujourd’hui ses résultats financiers semestriels au 30 juin 2026 et présente un point sur ses activités
09/10/2026
COMMUNIQU É DE PRESSE AB SCIENCE PRÉSENTE SES RÉSULTATS FINANCIERS AU PREMIER SEMESTRE 2026 ET LES ÉVÉNEMENTS CLEFS DE LA PÉRIODE Évolution de la gouvernance d’AB Science et mise en place d’une nouvelle stratégie [...]
EssilorLuxottica: Third-Quarter 2026 Revenue Conference Call Invitation
09/10/2026
Third-Quarter 2026 Revenue Conference Call Invitation Mr STEFANO GRASSI, Chief Financial Officer, and Mr GIORGIO IANNELLA, Head of Investor Relations, have the pleasure of inviting you to our Third-Quarter 2026 Revenue [...]
EssilorLuxottica: Third-Quarter 2026 Revenue Conference Call Invitation
09/10/2026
Third-Quarter 2026 Revenue Conference Call Invitation Mr STEFANO GRASSI, Chief Financial Officer, and Mr GIORGIO IANNELLA, Head of Investor Relations, have the pleasure of inviting you to our Third-Quarter 2026 Revenue [...]
How to Tell Whether an E-commerce Brand Has Outgrown Its In-House Customer Support
09/10/2026
Transcom's Retail Peak Resilience Index finds cost per order can triple while order volume doubles in operating models tuned to an average week Promotion backlogs, coverage gaps and routine contacts crowding out [...]
Eupraxia Pharmaceuticals to Present at Upcoming American College of Gastroenterology (ACG) and United European Gastroenterology (UEG) Medical Conferences
09/10/2026
VANCOUVER, British Columbia, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary [...]
Arcutis Presents ZORYVE® (roflumilast) Data and Real-World Topical Corticosteroid Research at EADV and Fall Clinical
09/10/2026
Presentation of data from the INTEGUMENT-INFANT trial of investigational ZORYVE cream 0.05% in infants ages 3 to <24 months, where treatment options remain limited New analyses from the ARRECTOR and DERMIS-1/2 trials [...]
Nextech Unveils Agentic AI Capabilities for Patient Experience through Partnerships with Assort Health and EliseAI
09/10/2026
Specialty practices gain a choice of two leading AI patient access platforms, unveiled at AAO 2026 in New Orleans TAMPA, Fla., Oct. 09, 2026 (GLOBE NEWSWIRE) -- Nextech , a leading technology partner for specialty [...]
Nuvectis Pharma to Participate in the Maxim Growth Summit 2026
09/10/2026
Fort Lee, NJ, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of innovative therapies for the [...]
Milestone Pharmaceuticals Announces First European Study Participant Enrolled in ReVeRA-301 Phase 3 Clinical Trial
09/10/2026
Dutch Cardiovascular Investigator Network (WCN) Leads European Enrollment in Phase 3 Study Evaluating Etripamil Nasal Spray for AFib-RVR MONTREAL and CHARLOTTE, N.C., Oct. 09, 2026 (GLOBE NEWSWIRE) -- Milestone ® [...]
Profound Medical and Telix Pharmaceuticals Enter Co-Education Agreement to Advance PSMA-Informed Prostate Care
09/10/2026
Collaboration will educate physicians and prostate cancer centers on the complementary roles of Telix’s PSMA-PET molecular imaging technologies and Profound’s MRI-guided TULSA-PRO ® Agreement provides Profound with [...]
Trillium Dental’s Dr. Mark Northcott Reveals Which Halloween Treats Damage Kids’ Teeth and Which Are Surprisingly Safe
09/10/2026
OTTAWA, Ontario, Oct. 09, 2026 (GLOBE NEWSWIRE) -- With Halloween approaching, Dr. Mark Northcott, co-founder of Trillium Dental and a Doctor of Dental Surgery from McGill University and Yale University, is advising [...]
Mineralys Therapeutics Presents New Data for Lorundrostat at the American Heart Association Hypertension Scientific Sessions 2026
09/10/2026
- New analyses from the pivotal Launch-HTN trial showed that 46% of participants with difficult-to-treat hypertension receiving lorundrostat 50 mg achieved the AHA/ACC Guideline systolic blood pressure target of <130 [...]
SkinHealth Systems Announces Reverse Stock Split
09/10/2026
Shares expected to begin trading on split-adjusted basis on October 14, 2026 LONG BEACH, Calif., Oct. 09, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems (Nasdaq: SKIN) (the “Company”), home to flagship brand Hydrafacial™, [...]

Pages